STAT March 27, 2020
Ed Silverman

As more companies gear up to fight the spread of the novel coronavirus, a growing number of government officials, lawmakers, academics, and advocacy groups are seeking to ensure widespread access to medical products for combating Covid-19.

Over the past two days, more than 30 members of the European Parliament and dozens of advocacy groups separately urged the European Commission to avoid granting monopolies that might allow manufacturers to eventually charge prices for medicines, vaccines, or diagnostics that would be out of reach for poorer populations around the world.

And World Health Organization Director General Tedros Adhanom Ghebreyesus tweeted that he “welcomes” a proposal made this week by Costa Rican President Carlos Alvarado Quesada to create a voluntary pool to collect...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Medical Devices, Patient / Consumer, Pharma, Provider, Trends
Will The White House’s Plan To Curb Drug Shortages Work?
Pharma Pulse 4/24/24: 5 Things You Should Know About Women's Health, Microsoft Makes Push Into Smaller AI Systems & more
New AI drug discovery powerhouse Xaira rises with $1B in funding
AI-enabled drug discovery company Xaira launches with $1B
25 most expensive hospital drugs

Share This Article